Orthofix Medical (OFIX) vs Pro-Dex (PDEX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Pro-Dex (PDEX) has outperformed Orthofix Medical (OFIX) over the past year, gaining 92.9% versus a loss of 60.2%. Over five years, PDEX leads with a +180.2% price change compared with -80.6% for OFIX. Orthofix Medical is the larger company by market cap ($247.4 million vs $201.6 million), about 1.2 times the size, while Pro-Dex is growing revenue faster (+16.5% vs +2.9%).
On valuation, Pro-Dex trades at a lower forward P/E (18.2x vs 33.7x for Orthofix Medical). Pro-Dex converts more of its revenue into profit, with a net margin of 17.6% versus -11.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OFIX | PDEX |
|---|---|---|
| Share price | $6.07 | $63.00 |
| Market cap | $247.41M | $201.60M |
| 1-day change | -4.26% | -0.77% |
| YTD return | -59.96% | +63.72% |
| 1-year return | -60.22% | +92.90% |
| 5-year return | -80.64% | +180.25% |
| P/E ratio (TTM) | — | 17.36 |
| Forward P/E | 33.72 | 18.16 |
| EPS (TTM) | $-1.10 | $3.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $822.31M | $77.55M |
| Revenue growth (YoY) | +2.85% | +16.45% |
| Net income (latest FY) | $-92.19M | $13.66M |
| Gross margin | 68.83% | 31.38% |
| Operating margin | -9.90% | 16.75% |
| Net margin | -11.21% | 17.62% |
| 52-week high | $16.42 | $77.00 |
| 52-week low | $6.04 | $32.14 |
| Distance from 52-week high | -63.03% | -18.18% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +64.74% | +26.98% |
| Average volume | 481.16K | 54.15K |
| Shares outstanding | 40.76M | 3.20M |
| Employees | 1,605 | 201 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PDEX has outperformed OFIX by 153.1 percentage points over the past year.
- Pro-Dex is more profitable, keeping 17.6 cents of every revenue dollar as net income versus -11.2 cents for Orthofix Medical.
- Pro-Dex grew revenue faster in its latest fiscal year (+16.45% vs +2.85%).
About Orthofix Medical
OFIX stock →Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.
Health Care · Medical/Dental Instruments · 1,605 employees
About Pro-Dex
PDEX stock →Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide.
Health Care · Medical/Dental Instruments · 201 employees
OFIX vs PDEX FAQ
Which is bigger, Orthofix Medical or Pro-Dex?
Orthofix Medical (OFIX) is larger, with a market capitalization of $247.41M compared with $201.60M for Pro-Dex (PDEX).
Which stock has performed better over the past year, OFIX or PDEX?
PDEX returned +92.90% over the past 12 months, compared with -60.22% for OFIX (price return, excluding dividends). Past performance does not predict future results.
Are Orthofix Medical and Pro-Dex in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.